Literature DB >> 6188843

Rise and fall of the delta globin gene.

S L Martin, K A Vincent, A C Wilson.   

Abstract

This paper examines the molecular basis for the origin and subsequent silencing of the delta globin gene during the evolution of higher primates. We cloned and sequenced the delta gene from representatives of the two most distantly related types of Old World monkeys in which the gene is silent. The silent delta genes of these two monkeys (rhesus and colobus) are highly homologous to each other (97.5%) and to the functional human delta gene (94%). The presumed mutation that silenced the delta gene is therefore unlikely to be obscured by later mutations at the same site. This silencing mutation could have affected transcription since we find no delta transcript in rhesus bone marrow. Furthermore, the delta globin genes from colobus and rhesus monkeys are many times less efficient than the human delta gene in a cell-free transcription assay. The two Old World monkeys share only three nucleotide substitutions in the first 100 base-pairs of the DNA sequence 5' to the site for initiation of transcription when compared to human delta. It is likely that the in vitro silencing of the delta gene was brought about by one (or a combination) of these three substitutions. Three analysis shows how the delta sequences are related to those for other beta-like genes, including the colobus beta gene whose sequence we report. One part of the delta gene appears to be derived from a (pseudo?) beta gene that diverged from beta before the divergence of mice and men. The other part is closely related to the beta gene of higher primates. The mosaic nature of the delta gene is apparently due to a partial conversion which took place between the pseudo beta and the functional beta gene before the divergence of the lineages leading to Old World monkeys and hominoids.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188843     DOI: 10.1016/0022-2836(83)90048-7

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  Gene conversion and functional divergence in the beta-globin gene family.

Authors:  Gabriela Aguileta; Joseph P Bielawski; Ziheng Yang
Journal:  J Mol Evol       Date:  2004-08       Impact factor: 2.395

2.  Extranuclear differentiation and gene flow in the finite island model.

Authors:  N Takahata; S R Palumbi
Journal:  Genetics       Date:  1985-02       Impact factor: 4.562

3.  The multiple origins of human Alu sequences.

Authors:  W Bains
Journal:  J Mol Evol       Date:  1986       Impact factor: 2.395

4.  The L1 family (KpnI family) sequence near the 3' end of human beta-globin gene may have been derived from an active L1 sequence.

Authors:  A Fujita; M Hattori; O Takenaka; Y Sakaki
Journal:  Nucleic Acids Res       Date:  1987-05-26       Impact factor: 16.971

5.  Comparison of human and chimpanzee zeta 1 globin genes.

Authors:  C Willard; E Wong; J F Hess; C K Shen; B Chapman; A C Wilson; C W Schmid
Journal:  J Mol Evol       Date:  1985       Impact factor: 2.395

6.  A novel delta zero-thalassemia arising from a frameshift insertion, detected by direct sequencing of enzymatically amplified DNA.

Authors:  M Losekoot; R Fodde; P C Giordano; L F Bernini
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

7.  DNA polymorphisms in the psi beta 1- and beta-globin gene regions in Asian macaques.

Authors:  K Shimizu; O Takenaka
Journal:  Biochem Genet       Date:  1991-04       Impact factor: 1.890

8.  Algorithms for restriction map comparisons.

Authors:  M S Waterman; T F Smith; H L Katcher
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

9.  Intergenic DNA sequences flanking the pseudo alpha globin genes of human and chimpanzee.

Authors:  I Sawada; M P Beal; C K Shen; B Chapman; A C Wilson; C Schmid
Journal:  Nucleic Acids Res       Date:  1983-11-25       Impact factor: 16.971

10.  Evolution of hemoglobin and its genes.

Authors:  Ross C Hardison
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.